Raaj Medisafe India Board to Review Preferential Share Sale

Raaj Medisafe India Limited's Board of Directors is set to meet on March 26, 2026.

The main item on the agenda is considering the issuance and allotment of 32,75,000 equity shares on a preferential basis.

Raising Capital and Shareholder Impact

This proposal is a key part of the company's strategy to secure funding. Preferential allotments allow companies to raise money from specific investors without a public offering. Such capital can support growth initiatives, acquisitions, or debt reduction. However, it typically results in dilution of existing shareholders' stakes.

Company Background and Previous Approvals

Raaj Medisafe India Limited, previously known as Manoj Surgical Industries Ltd., produces packaging solutions and hygiene products. In December 2025, the board had already approved plans to raise up to ₹18 Crores through a preferential issue. Shareholders approved the allotment of 32,75,000 equity shares at ₹55 each to non-promoters during an Extraordinary General Meeting on January 20, 2026. This current proposal is expected to align with the company's approved expansion plans and its planned acquisition of Goa-based Fabrizo Industries Pvt. Ltd. for ₹28 Crores. Recent financial updates show growth in revenue and profit, though the company has seen an increase in its debtor days.

Impact of Share Allotment

If the preferential allotment is approved, Raaj Medisafe India's equity base will grow. This will adjust the company's capital structure and could potentially dilute earnings per share (EPS) for current shareholders. The capital infusion is anticipated to bolster the company's strategic growth initiatives and acquisitions.

Key Risks and Considerations

Investors will be focused on the final terms and pricing of the preferential issue. The effective use of the raised funds for expansion and acquisition will be a critical measure of future success. A notable increase in debtor days to 97.6 from 76.3 indicates potential pressure on working capital management that requires attention.

Industry Peers

Raaj Medisafe operates in the packaging and hygiene product sectors. Competitors in packaging include EPL Limited and AGI Greenpac Limited, both listed on stock exchanges. In the broader medical and hygiene products market, companies like Poly Medicure Ltd. are also significant players. These peers generally have much larger market capitalizations compared to Raaj Medisafe India Ltd.

Financial Performance Highlights (Q3 FY25-26)

As of the third quarter of fiscal year 2025-26, Raaj Medisafe India Ltd reported revenue of ₹20.75 Crore, marking a 42.32% year-on-year increase. Net profit for the same period reached ₹1.89 Crore, up 83.5% compared to the prior year.

Next Steps for Investors

Investors are awaiting the Board of Directors' final decision on the preferential allotment. Details regarding the specific allottees and the exact terms of the issuance will be crucial. Following that, the deployment of funds towards expansion and acquisition will serve as a key indicator for the company's future performance.